Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer

Fluoropyrimidines, oxaliplatin, irinotecan and biologic therapies (Bevacizumab, Panitumumab, and Cetuximab) represent the backbone of metastatic colorectal cancer (CRC) treatment. The improvement in survival for mCRC patient led to two main outstanding issues: 1) there is a significant number of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonini, Giuseppe, Imperatori, Marco, Vincenzi, Bruno, Frezza, Anna Maria, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874688/
https://www.ncbi.nlm.nih.gov/pubmed/24245912
http://dx.doi.org/10.1186/1756-9966-32-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874688/
https://www.ncbi.nlm.nih.gov/pubmed/24245912
http://dx.doi.org/10.1186/1756-9966-32-92

Ejemplares similares